Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study

Table 3

Changes in mean BG, total BG, insulin dose, and PSL dose before and after starting IGF-1.

Hospital day	IGF-1 dose (mg/kg)	Insulin dose (unit/day)	PSL (mg/day)	Mean BG (mg/dL)/(mmol/L)	Total BG (mg/dL)/(mmol/L)	Difference of BG (mg/dL)/(mmol/L)
35	—	170	—	435/24.2	1738/96.6
36	—	170	—	435/24.2	1738/96.6	163/9.06
37	0.1	170	—	394/21.9	1575/87.5
38	0.1	140	—	389/21.6	1556/86.4
39	0.1	100	—	395/21.9	1578/87.7
40	0.125	50	—	438/24.3	1751/97.3
41	0.125	0	30	466/25.9	1863/103.5
42	0.125	0	30	526/29.2	2103/116.8
43	0.125	0	30	511/28.4	2045/113.6

Mean blood glucose was calculated as the average of four measurements (before each meal and sleep (approximately 2 h after dinner)). Total blood glucose was calculated as the total amount of the above four measurements. IGF-1: insulin-like growth factor-1; PSL: prednisolone; BG: blood glucose.